“…There are several reported studies that analyze the skin and follicular permeation of drug delivery systems (Abd et al, 2018;Blume-Peytavi et al, 2010;Lauterbach and Müller-Goymann, 2015;Ossadnik et al, 2006;Patzelt et al, 2011;Teichmann et al, 2007). Recently, some nanocarriers were developed to deliver topically drugs with interesting potential to treat acne vulgaris, hidradenitis suppurativa, androgenic alopecia and inflammation-based skin and hair disorders (Angelo et al, 2020;Pereira et al, 2021;Tolentino et al, 2021;Ushirobira et al, 2020). The authors have compared the developed vehicles with commercial ones or with the drug in solution and they have elegantly quantified which percentage of the drug penetrated into the skin specifically through the follicular pathway (Angelo et al, 2020;Pereira et al, 2021;Tolentino et al, 2021;Ushirobira et al, 2020).…”